{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T11:24:35Z","timestamp":1788175475969,"version":"build-2803163510"},"reference-count":97,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,9]],"date-time":"2026-08-09T00:00:00Z","timestamp":1786233600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100015774","name":"University of Malta","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100015774","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.ejpb.2026.115211","type":"journal-article","created":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T23:46:13Z","timestamp":1786491973000},"page":"115211","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["A systematic review of 3D printing of pharmaceutical drug products: Barriers and enablers"],"prefix":"10.1016","volume":"227","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-7494-8929","authenticated-orcid":false,"given":"Elton","family":"Gatt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9499-5875","authenticated-orcid":false,"given":"Nicolette Sammut","family":"Bartolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3811-0761","authenticated-orcid":false,"given":"Lilian M","family":"Azzopardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.ejpb.2026.115211_b0450","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.3390\/jpm14111080","article-title":"Three-Dimensional Printing Technology in Drug Design and Development: Feasibility, challenges, and potential applications","volume":"14","author":"Simon","year":"2024","journal-title":"Journal of Personalized Medicine"},{"issue":"2","key":"10.1016\/j.ejpb.2026.115211_b0445","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics15020313","article-title":"3D Printing Technologies in Personalized Medicine, Nanomedicines, and Biopharmaceuticals","volume":"15","author":"Serrano","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ejpb.2026.115211_b0470","first-page":"319","article-title":"Additive manufacturing of pharmaceuticals for precision medicine applications: a review of the promises and perils in implementation","volume":"23","author":"Trivedi","year":"2018","journal-title":"Addit. Manuf."},{"issue":"2","key":"10.1016\/j.ejpb.2026.115211_b0110","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s40964-020-00127-5","article-title":"Current formulation approaches in design and development of solid oral dosage forms through three-dimensional printing","volume":"5","author":"Curti","year":"2020","journal-title":"Prog. Addit. Manuf."},{"issue":"2","key":"10.1016\/j.ejpb.2026.115211_b0500","doi-asserted-by":"crossref","first-page":"416","DOI":"10.3390\/pharmaceutics15020416","article-title":"A Review of 3D Printing Technology in Pharmaceutics: Technology and applications, now and Future","volume":"15","author":"Wang","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ejpb.2026.115211_b0250","unstructured":"Khairuzzaman, A. (2018). In Basit A. W., Gaisford S.(Eds.), 3D Printing of Pharmaceuticals [Regulatory Perspectives on 3D Printing in Pharmaceuticals] (1st ed.). Springer Cham. Doi: 10.1007\/978-3-319-90755-0."},{"issue":"3","key":"10.1016\/j.ejpb.2026.115211_b0015","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.xphs.2021.08.032","article-title":"Re-Envisioning Pharmaceutical Manufacturing: increasing Agility for Global Patient Access","volume":"111","author":"Algorri","year":"2022","journal-title":"J. Pharm. Sci."},{"issue":"9","key":"10.1016\/j.ejpb.2026.115211_b0225","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1007\/s11095-018-2454-x","article-title":"3D Printing in Pharmaceutical and Medical applications - recent Achievements and challenges","volume":"35","author":"Jamr\u00f3z","year":"2018","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejpb.2026.115211_b0295","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.addr.2018.05.006","article-title":"3D printed drug delivery and testing systems - a passing fad or the future?","volume":"132","author":"Lim","year":"2018","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejpb.2026.115211_b0370","article-title":"PRISMA 2020 explanation and elaboration: updated guidance and exemplars for reporting systematic reviews","author":"Page","year":"2021","journal-title":"BMJ"},{"issue":"1","key":"10.1016\/j.ejpb.2026.115211_b0455","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/1471-2288-8-45","article-title":"Methods for the thematic synthesis of qualitative research in systematic reviews","volume":"8","author":"Thomas","year":"2008","journal-title":"BMC Med. Res. Method."},{"key":"10.1016\/j.ejpb.2026.115211_b0495","doi-asserted-by":"crossref","unstructured":"Waffenschmidt, Knelangen, Sieben, B\u00fchn, & Pieper. (2019). Single screening versus conventional double screening for study selection in systematic reviews: a methodological systematic review. BMC Medical Research Methodology, 19(1)10.1186\/s12874-019-0782-0.","DOI":"10.1186\/s12874-019-0782-0"},{"issue":"11","key":"10.1016\/j.ejpb.2026.115211_b0145","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1002\/sim.1190","article-title":"Identification of randomised controlled trials in systematic reviews: accuracy and reliability of screening records","volume":"21","author":"Edwards","year":"2002","journal-title":"Stat. Med."},{"key":"10.1016\/j.ejpb.2026.115211_b0460","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2024.123867","article-title":"Perspectives on 3D printed personalized medicines for pediatrics","volume":"653","author":"Tong","year":"2024","journal-title":"Int. J. Pharm."},{"issue":"1","key":"10.1016\/j.ejpb.2026.115211_b0045","doi-asserted-by":"crossref","DOI":"10.1115\/1.4056199","article-title":"A Review of State-of-the-Art on Enabling Additive Manufacturing Processes for Precision Medicine","volume":"145","author":"Awad","year":"2023","journal-title":"Journal of Manufacturing Science and Engineering-Transactions of the Asme"},{"key":"10.1016\/j.ejpb.2026.115211_b0355","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2024.123902","article-title":"Application of 3D printing in early phase development of pharmaceutical solid dosage forms","volume":"653","author":"Milliken","year":"2024","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2026.115211_b0360","doi-asserted-by":"crossref","unstructured":"Mohammed, A. A., Algahtani, M. S., Ahmad, M. Z., Ahmad, J., & Kotta, S. (2021). 3D Printing in medicine: Technology overview and drug delivery applications. Annals of 3D Printed Medicine, 410.1016\/j.stlm.2021.100037.","DOI":"10.1016\/j.stlm.2021.100037"},{"issue":"6","key":"10.1016\/j.ejpb.2026.115211_b0090","first-page":"38","article-title":"The promising role of semi-solid extrusion technology in custom drug formulation for pediatric medicine","volume":"10","author":"Cerveto","year":"2024","journal-title":"International Journal of Bioprinting"},{"issue":"1","key":"10.1016\/j.ejpb.2026.115211_b0395","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/s43094-022-00439-z","article-title":"3D printing of pharmaceuticals: approach from bench scale to commercial development","volume":"8","author":"Pawar","year":"2022","journal-title":"Future Journal of Pharmaceutical Sciences"},{"issue":"1","key":"10.1016\/j.ejpb.2026.115211_b0070","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1007\/s43441-022-00436-7","article-title":"Magistral compounding with 3D Printing: a Promising Way to Achieve Personalized Medicine","volume":"57","author":"Beer","year":"2023","journal-title":"Ther. Innov. Regul. Sci."},{"issue":"2","key":"10.1016\/j.ejpb.2026.115211_b0275","doi-asserted-by":"crossref","first-page":"416","DOI":"10.3390\/pharmaceutics14020416","article-title":"3D Printing of Pediatric Medication: the end of Bad Tasting Oral Liquids?-a Scoping Review","volume":"14","author":"Lafeber","year":"2022","journal-title":"Pharmaceutics"},{"issue":"1","key":"10.1016\/j.ejpb.2026.115211_b0305","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s41205-023-00172-0","article-title":"Customizable document control solution for 3D printing at the point-of-care","volume":"9","author":"Lohss","year":"2023","journal-title":"Printing in Medicine"},{"issue":"12","key":"10.1016\/j.ejpb.2026.115211_b0420","first-page":"22","article-title":"Legal and Regulatory Perspectives on 3D Printing: Drug compounding applications","volume":"48","author":"Ritchie","year":"2024","journal-title":"Pharm. Technol. Eur."},{"key":"10.1016\/j.ejpb.2026.115211_b0135","doi-asserted-by":"crossref","unstructured":"Durga Prasad Reddy, R., & Sharma, V. (2020). Additive manufacturing in drug delivery applications: A review. International Journal of Pharmaceutics, 58910.1016\/j.ijpharm.2020.119820.","DOI":"10.1016\/j.ijpharm.2020.119820"},{"issue":"2","key":"10.1016\/j.ejpb.2026.115211_b0055","doi-asserted-by":"crossref","first-page":"124","DOI":"10.3390\/pharmaceutics12020124","article-title":"Polymers for Extrusion-based 3D Printing of Pharmaceuticals: a Holistic Materials-Process Perspective","volume":"12","author":"Azad","year":"2020","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ejpb.2026.115211_b0060","article-title":"3D printing of pharmaceuticals and the role of pharmacy","author":"Basit","year":"2022","journal-title":"Pharmaceutical Journal"},{"key":"10.1016\/j.ejpb.2026.115211_b0465","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2022.122480","article-title":"3D printing: innovative solutions for patients and pharmaceutical industry","volume":"631","author":"Tracy","year":"2023","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2026.115211_b0265","doi-asserted-by":"crossref","DOI":"10.1016\/j.jddst.2024.106072","article-title":"Recent Advancements in Pharmaceutical 3D Printing Industry","volume":"100","author":"Kulkarni","year":"2024","journal-title":"J. Drug Delivery Sci. Technol."},{"key":"10.1016\/j.ejpb.2026.115211_b0390","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.addr.2021.04.020","article-title":"Controlling drug release with additive manufacturing-based solutions","volume":"174","author":"Patel","year":"2021","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"1","key":"10.1016\/j.ejpb.2026.115211_b0050","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/j.ijpharm.2018.07.024","article-title":"3D printed medicines: a new branch of digital healthcare","volume":"548","author":"Awad","year":"2018","journal-title":"Int. J. Pharm."},{"issue":"2","key":"10.1016\/j.ejpb.2026.115211_b0260","doi-asserted-by":"crossref","first-page":"229","DOI":"10.2478\/acph-2024-0012","article-title":"The potential of three-dimensional printing for pediatric oral solid dosage forms","volume":"74","author":"Kreft","year":"2024","journal-title":"Acta Pharm. (Zagreb, Croatia)"},{"key":"10.1016\/j.ejpb.2026.115211_b0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2024.125089","article-title":"3D printing for controlled release Pharmaceuticals: current trends and future directions","volume":"669","author":"Deng","year":"2025","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2026.115211_b0335","doi-asserted-by":"crossref","unstructured":"Melnyk, L. A., & Oyewumi, M. O. (2021). Integration of 3D printing technology in pharmaceutical compounding: Progress, prospects, and challenges. Annals of 3D Printed Medicine, 410.1016\/j.stlm.2021.100035.","DOI":"10.1016\/j.stlm.2021.100035"},{"issue":"9","key":"10.1016\/j.ejpb.2026.115211_b0075","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1016\/j.drudis.2020.07.007","article-title":"3D printing for drug delivery and biomedical applications","volume":"25","author":"Beg","year":"2020","journal-title":"Drug Discov. Today"},{"issue":"12","key":"10.1016\/j.ejpb.2026.115211_b0210","doi-asserted-by":"crossref","first-page":"3524","DOI":"10.1016\/j.xphs.2020.09.025","article-title":"The Confluence of Innovation in Therapeutics and Regulation: recent CMC Considerations","volume":"109","author":"Gutierrez","year":"2020","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2026.115211_b0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.rcsop.2021.100073","article-title":"Scenarios for 3D printing of personalized medicines - a case study","volume":"4","author":"Beer","year":"2021","journal-title":"Exploratory Research in Clinical and Social Pharmacy"},{"key":"10.1016\/j.ejpb.2026.115211_b0195","unstructured":"FDA. (2004). Guidance for Industry PAT -A Framework for Innovative Pharmaceutical Development, Manufacturing, and Quality Assurance. Center for Drug Evaluation and Research."},{"issue":"6","key":"10.1016\/j.ejpb.2026.115211_b0235","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.tips.2023.03.006","article-title":"Advancing non-destructive analysis of 3D printed medicines","volume":"44","author":"J\u00f8rgensen","year":"2023","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.ejpb.2026.115211_b0425","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2025.125251","article-title":"Advancing medication compounding: use of a pharmaceutical 3D printer to auto-fill minoxidil capsules for dispensing to patients in a community pharmacy","volume":"671","author":"Rodriguez-Macineiras","year":"2025","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2026.115211_b0410","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.addr.2021.02.013","article-title":"Versatility on demand - the case for semi-solid micro-extrusion in pharmaceutics","volume":"172","author":"Rahman","year":"2021","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejpb.2026.115211_b0340","article-title":"From Digital Design to Dosage Performance: Material-Process-Geometry Interactions in 3D-printed Oral Tablets","volume":"27(4)10.1208\/s12249-026-03437-z","author":"Menkudale","year":"2026","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.ejpb.2026.115211_b0140","doi-asserted-by":"crossref","unstructured":"Eddaou, I., Bom, S., Gra\u00e7a, A., & Marto, J. (2026). Beyond spectroscopy: Machine vision as the future of non-destructive testing in 3D-printed pharmaceuticals. International Journal of Pharmaceutics, 69410.1016\/j.ijpharm.2026.126750.","DOI":"10.1016\/j.ijpharm.2026.126750"},{"key":"10.1016\/j.ejpb.2026.115211_b0200","doi-asserted-by":"crossref","DOI":"10.1007\/s13346-026-02059-z","article-title":"Translation of pharmaceutical 3D printing to clinical point-of-care and industrial manufacturing","author":"Gioumouxouzis","year":"2026","journal-title":"Drug Deliv. Transl. Res."},{"key":"10.1016\/j.ejpb.2026.115211_b0005","doi-asserted-by":"crossref","unstructured":"Ahmed, A. A., Schimmel, K. J. M., Tubic-Grozdanis, M., Tuleu, C., Smith, J., Soulairol, I., Dadkhah, A., Paulson, M., Lechanteur, A., Carrez, L., Schnor, T., Lagarce, F., Le Brun, P.,P.H., & Crauste-Manciet, S. (2025). Expert opinion on extrusion-based pharmaceutical 3D printing from the European Society of Hospital Pharmaceutical Technology (GERPAC). International Journal of Pharmaceutics, 686, 126321. 10.1016\/j.ijpharm.2025.126321.","DOI":"10.1016\/j.ijpharm.2025.126321"},{"issue":"8","key":"10.1016\/j.ejpb.2026.115211_b0095","doi-asserted-by":"crossref","first-page":"513","DOI":"10.2174\/0113894501304163240429081741","article-title":"Revolutionizing the World of Pharmaceuticals: Unleashing the Game-changing Power of 3D Printing","volume":"25","author":"Chahuan","year":"2024","journal-title":"Curr. Drug Targets"},{"key":"10.1016\/j.ejpb.2026.115211_b0385","doi-asserted-by":"crossref","DOI":"10.1016\/j.bprint.2025.e00437","article-title":"AI-powered transformation of pharmaceutical 3D printing: enhancing precision, efficiency, and personalization","volume":"50","author":"Patel","year":"2025","journal-title":"Bioprinting"},{"key":"10.1016\/j.ejpb.2026.115211_b0315","unstructured":"Madla, C. M., Trenfield, S. J., Goyanes, A., Gaisford, S., & Basit, A. W. (2018). In Basit A. W., Gaisford S.(Eds.), 3D Printing of Pharmaceuticals [3D Printing Technologies, Implementation and Regulation: An Overview] (1st ed.). Springer Cham. Doi: 10.1007\/978-3-319-90755-0."},{"key":"10.1016\/j.ejpb.2026.115211_b0125","article-title":"Additively manufactured medical products \u2013 the FDA perspective","author":"Di Prima","year":"2016","journal-title":"Springer Science and Business Media LLC"},{"issue":"1","key":"10.1016\/j.ejpb.2026.115211_b0255","doi-asserted-by":"crossref","first-page":"481","DOI":"10.25258\/ijddt.14.1.67","article-title":"A Comprehensive Review on 3D Printing of Pharmaceuticals","volume":"14","author":"Korni","year":"2024","journal-title":"International Journal of Drug Delivery Technology"},{"issue":"3","key":"10.1016\/j.ejpb.2026.115211_b0035","doi-asserted-by":"crossref","first-page":"609","DOI":"10.3390\/pharmaceutics14030609","article-title":"The Advent of a New Era in Digital Healthcare: a Role for 3D Printing Technologies in Drug Manufacturing?","volume":"14","author":"Andreadis","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ejpb.2026.115211_b0240","article-title":"3D printing in personalized medicines: a focus on applications of the technology","volume":"35","author":"Kalyan","year":"2023","journal-title":"Mater. Today Commun."},{"key":"10.1016\/j.ejpb.2026.115211_b0320","doi-asserted-by":"crossref","DOI":"10.1016\/j.jddst.2024.105839","article-title":"Revolutionizing drug delivery: Exploring the impact of advanced 3D printing technologies on polymer-based systems","volume":"98","author":"Majrashi","year":"2024","journal-title":"J. Drug Delivery Sci. Technol."},{"key":"10.1016\/j.ejpb.2026.115211_b0280","article-title":"Additive manufacturing technologies with emphasis on stereolithography 3D printing in pharmaceutical and medical applications: a review","volume":"5","author":"Lakkala","year":"2023","journal-title":"International Journal of Pharmaceutics: X"},{"key":"10.1016\/j.ejpb.2026.115211_b0085","article-title":"MHRA publishes 'world first' decentralised manufacturing guidance","author":"Burns","year":"2025","journal-title":"Pharm. J."},{"key":"10.1016\/j.ejpb.2026.115211_b0345","unstructured":"MHRA. (2025a, 10 June). Decentralised manufacture: The designation step. Retrieved 22 June 2025, from https:\/\/www.gov.uk\/guidance\/decentralised-manufacture-the-designation-step."},{"key":"10.1016\/j.ejpb.2026.115211_b0350","unstructured":"MHRA. (2025b, 10 June). Human medicines Modular Manufacture and Point of Care regulations 2025: Overview. https:\/\/www.gov.uk\/government\/publications\/human-medicines-modular-manufacture-and-point-of-care-regulations-2025-overview\/human-medicines-modular-manufacture-and-point-of-care-regulations-2025-overview."},{"key":"10.1016\/j.ejpb.2026.115211_b0490","article-title":"Integrating 3D Printing and Additive Manufacturing into Personalized Medicine for Pharmaceuticals: Opportunities, Limitations, and Future Perspectives","volume":"93(4)10.3390\/scipharm93040061","author":"Vidiyala","year":"2025","journal-title":"Sci. Pharm."},{"key":"10.1016\/j.ejpb.2026.115211_b0285","unstructured":"Lalitha, A. K., Raghava, D., rao, K. N., & Sravani, P. N. (2025). Regulatory Hurdles in the Commercialization of 3D Printed Pharmaceuticals and Medical Devices. Journal of Cardiovascular Disease Research (Journal of Cardiovascular Disease Research), 16(10), 138\u2013145. https:\/\/research.ebsco.com\/plink\/614b980c-411e-3ba5-851e-d047c204f473."},{"issue":"10","key":"10.1016\/j.ejpb.2026.115211_b0290","first-page":"704","article-title":"Medical applications for 3D printing: current and projected uses","volume":"39","author":"Lee Ventola","year":"2014","journal-title":"P and T"},{"issue":"2","key":"10.1016\/j.ejpb.2026.115211_b0130","article-title":"3D printing - 3D printed drugs hold great potential for personalized medicine","volume":"18","author":"Dubin","year":"2018","journal-title":"Drug Development and Delivery"},{"issue":"4","key":"10.1016\/j.ejpb.2026.115211_b0325","doi-asserted-by":"crossref","first-page":"321","DOI":"10.18063\/ijb.v8i4.622","article-title":"Three-Dimensional Printing Technologies for Drug Delivery Applications: Processes, Materials, and Effects","volume":"8","author":"Mancilla-De-la-Cruz","year":"2022","journal-title":"International Journal of Bioprinting"},{"issue":"8","key":"10.1016\/j.ejpb.2026.115211_b0080","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1080\/03091902.2020.1822942","article-title":"Aspects of 3D printed drugs","volume":"44","author":"Bhattacharjee","year":"2020","journal-title":"J. Med. Eng. Technol."},{"issue":"2","key":"10.1016\/j.ejpb.2026.115211_b0505","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/s13181-020-00814-3","article-title":"Pharmaceutical compounding: a history, Regulatory Overview, and Systematic Review of compounding Errors","volume":"17","author":"Watson","year":"2021","journal-title":"J. Med. Toxicol."},{"key":"10.1016\/j.ejpb.2026.115211_b0020","doi-asserted-by":"crossref","unstructured":"Alhnan, M. A., Okwuosa, T. C., Sadia, M., Wan, K. -., Ahmed, W., & Arafat, B. (2016). Emergence of 3D Printed Dosage Forms: Opportunities and Challenges. Pharmaceutical Research, 33(8), 1817\u20131832. 10.1007\/s11095-016-1933-1.","DOI":"10.1007\/s11095-016-1933-1"},{"key":"10.1016\/j.ejpb.2026.115211_b0030","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.646836","article-title":"Practicality of 3D Printed Personalized Medicines in Therapeutics","volume":"12","author":"Amekyeh","year":"2021","journal-title":"Front. Pharmacol."},{"issue":"4","key":"10.1016\/j.ejpb.2026.115211_b0475","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1016\/j.survophthal.2022.01.004","article-title":"Applications of three-dimensional printing in ophthalmology","volume":"67","author":"Tsui","year":"2022","journal-title":"Surv. Ophthalmol."},{"issue":"3","key":"10.1016\/j.ejpb.2026.115211_b0215","doi-asserted-by":"crossref","first-page":"S411","DOI":"10.5530\/ijper.54.3s.139","article-title":"3D-printed drugs: a Fabrication of Pharmaceuticals towards Personalized Medicine","volume":"54","author":"Haris","year":"2020","journal-title":"Indian Journal of Pharmaceutical Education and Research"},{"key":"10.1016\/j.ejpb.2026.115211_b0230","unstructured":"Jewell, C., & Stones, J. (2018). In Basit A. W., Gaisford S.(Eds.), 3D Printing of Pharmaceuticals [3D Printing Techniques in the Pharmaceutical Sciences - Intellectual Property Issues] (1st ed.). Springer Cham. Doi: 10.1007\/978-3-319-90755-0."},{"key":"10.1016\/j.ejpb.2026.115211_b0270","doi-asserted-by":"crossref","unstructured":"Kumari, J., Pandey, S., Jangde, K. K., Kumar, P. V., & Mishra, D. K. (2024). Evolution, integration, and challenges of 3D printing in pharmaceutical applications: A comprehensive review. Bioprinting, 4410.1016\/j.bprint.2024.e00367.","DOI":"10.1016\/j.bprint.2024.e00367"},{"key":"10.1016\/j.ejpb.2026.115211_b0180","unstructured":"EU. (1989). Council Directive 89\/105\/EEC of 21 December 1988 relating to the transparency of measures regulating the prices of medicinal products for human use and their inclusion in the scope of national health insurance systems. Official Journal of the European Communities, https:\/\/eur-lex.europa.eu\/legal-content\/EN\/TXT\/PDF\/?uri=CELEX:31989L0105."},{"key":"10.1016\/j.ejpb.2026.115211_b0190","unstructured":"EU. (2021). Regulation (EU) 2021\/2282 of the European Parliament and of the Council of 15 December 2021 on health technology assessment and amending Directive 2011\/24\/EU. Official Journal of the European Union, https:\/\/eur-lex.europa.eu\/legal-content\/EN\/TXT\/PDF\/?uri=CELEX:32021R2282."},{"key":"10.1016\/j.ejpb.2026.115211_b0365","unstructured":"NICE. (2023). NICE health technology evaluations: the manual. https:\/\/www.nice.org.uk\/guidance\/GID-NGC10018\/documents\/642."},{"key":"10.1016\/j.ejpb.2026.115211_b0100","unstructured":"CMS. (2019). Medicare Program Integrity Manual: Chapter 13 - Local Coverage Determinations (CMS Pub. No. 100-08, Rev. 863). https:\/\/www.cms.gov\/regulations-and-guidance\/guidance\/manuals\/downloads\/pim83c13.pdf."},{"key":"10.1016\/j.ejpb.2026.115211_b0185","unstructured":"EU. (2007). Regulation (EC) No 1394\/2007 of the European Parliament and of the Council of 13 November 2007 on advanced therapy medicinal products and amending Directive 2001\/83\/EC and Regulation (EC) No 726\/2004. Official Journal of the European Union, https:\/\/eur-lex.europa.eu\/legal-content\/EN\/TXT\/PDF\/?uri=CELEX:32007R1394."},{"issue":"8","key":"10.1016\/j.ejpb.2026.115211_b0330","article-title":"FDA and the emerging technology of 3D printing","volume":"40","author":"Markarian","year":"2016","journal-title":"Pharm. Technol."},{"key":"10.1016\/j.ejpb.2026.115211_b0435","doi-asserted-by":"crossref","unstructured":"Sen, Mehta, Sansare, Sharifi, Ma, & Chaudhuri. (2021). Pharmaceutical applications of powder-based binder jet 3D printing process \u2013 A review. Elsevier BV. 10.1016\/j.addr.2021.113943.","DOI":"10.1016\/j.addr.2021.113943"},{"key":"10.1016\/j.ejpb.2026.115211_b0010","doi-asserted-by":"crossref","unstructured":"Algahtani, M. S. (2025). Public perspectives on 3D printed medications: Insight for formulation design and regulatory development. European Journal of Pharmaceutical Sciences, 21210.1016\/j.ejps.2025.107181.","DOI":"10.1016\/j.ejps.2025.107181"},{"key":"10.1016\/j.ejpb.2026.115211_b0405","unstructured":"Pharma3DPI. (2025). International Pharmaceutical 3D printing Initiative (Pharma3DPI). https:\/\/pharma3dpi.org\/home. Retrieved 06 September 2025, from."},{"key":"10.1016\/j.ejpb.2026.115211_b0485","unstructured":"US FDA. (2023). Distributed Manufacturing of Drugs: Stakeholder Feedback and Action Plan. Center for Drug Evaluation and Research."},{"key":"10.1016\/j.ejpb.2026.115211_b0150","unstructured":"Eglovitch, J. S. (2025, 10 June). MHRA releases spate of new guidelines on decentralized manufacturing. https:\/\/www.raps.org\/news-and-articles\/news-articles\/2025\/6\/mhra-releases-spate-of-new-guidelines-on-decentral."},{"key":"10.1016\/j.ejpb.2026.115211_b0380","doi-asserted-by":"crossref","first-page":"3078","DOI":"10.1007\/s13346-025-01868-y","article-title":"A framework for conducting clinical trials involving 3D printing of medicines at the point-of-care","volume":"15","author":"Parramon-Teixido","year":"2025","journal-title":"Drug Deliv. Transl. Res."},{"key":"10.1016\/j.ejpb.2026.115211_b0165","unstructured":"EMA. (2025). Quality Innovation Group (QIG): Listen and Learn Focus Group (LLFG) on Personalised Medicines \u2013 meeting report 8 \u2013 9 April 2025EMA\/244165\/2025. European Medicines Agency. https:\/\/www.ema.europa.eu\/en\/documents\/report\/meeting-report-quality-innovation-group-qig-listen-learn-focus-group-llfg-personalised-medicines_en.pdf."},{"key":"10.1016\/j.ejpb.2026.115211_b0175","unstructured":"EMA. (2026). Questions & Answers on the Implementation of 3DP Technology (Additive Manufacturing Technology) for Solid Oral Dosage FormsEMA\/CHMP\/CVMP\/QIG\/GMP\/QWP\/55150\/2026. European Medicines Agency."},{"key":"10.1016\/j.ejpb.2026.115211_b0220","unstructured":"ICH. (2025). ICH Reflection Paper: Proposed ICH Guideline Work to Facilitate the Adoption of Advanced Pharmaceutical Manufacturing T. International Council for Harmonisation."},{"key":"10.1016\/j.ejpb.2026.115211_b0120","doi-asserted-by":"crossref","unstructured":"Desai, P., Bang, K., Wang, J., Chan, P., Hsu, D., Hata, M., & Prabhu, S. (2026). Three-Dimensional Printing for Precision and Personalized Patient Care: A New Paradigm for Pharmacy Practice? Pharmaceutics, 18(2)10.3390\/pharmaceutics18020158.","DOI":"10.3390\/pharmaceutics18020158"},{"key":"10.1016\/j.ejpb.2026.115211_b0105","doi-asserted-by":"crossref","unstructured":"Coppens, D. G. M. &., Hoekman, J., De Bruin, M. L. &., Slaper-Cortenbach, I. C. M. &., Leufkens, H. G. M. &., Meij, P., & Gardarsdottir, H. (2020). Advanced therapy medicinal product manufacturing under the hospital exemption and other exemption pathways in seven European Union countries. Cytotherapy, 22(10), 592\u2013600. Doi: 10.1016\/j.jcyt.2020.04.092.","DOI":"10.1016\/j.jcyt.2020.04.092"},{"key":"10.1016\/j.ejpb.2026.115211_b0310","doi-asserted-by":"crossref","unstructured":"Lyousoufi, M., Lafeber, I.,&nbsp, Kweekel, D., de Winter, B. C. M., Swen, J. J., Le Brun, P. P. H., Bijleveld-Olierook, E. C. M., van Gelder, T.,&nbsp, Guchelaar, H., Moes, D. J. A. R., & Schimmel, K. J. M. (2023). Development and Bioequivalence of 3D-PrintedMedication at the Point-of-Care: Bridging the Gap Toward Personalized Medicine. Clinical Pharmacology & Therapeutics, 113(5), 1125\u20131131. 10.1002\/cpt.2870.","DOI":"10.1002\/cpt.2870"},{"key":"10.1016\/j.ejpb.2026.115211_b0440","article-title":"Visualizing disintegration of 3D printed tablets in humans using MRI and comparison with in vitro data","author":"Seoane-Via\u00f1o","year":"2023","journal-title":"Elsevier BV"},{"key":"10.1016\/j.ejpb.2026.115211_b0205","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2019.118497","article-title":"Automated therapy preparation of isoleucine formulations using 3D printing for the treatment of MSUD: first single-centre, prospective, crossover study in patients","volume":"567","author":"Goyanes","year":"2019","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2026.115211_b0300","doi-asserted-by":"crossref","unstructured":"Liu, L., Fu, K., Hong, S., Wang, Z., Mo, M., Li, S., Yu, Y., Chen, J., Chen, J., Zeng, W., Chen, J., & Yang, F. (2023). Improving the quality and clinical efficacy of subdivided levothyroxine sodium tablets by 3D printing technology. Journal of Drug Delivery Science and Technology, 8910.1016\/j.jddst.2023.105008.","DOI":"10.1016\/j.jddst.2023.105008"},{"key":"10.1016\/j.ejpb.2026.115211_b0430","article-title":"Paediatric clinical study of 3D printed personalised medicines for rare metabolic disorders","author":"Rodr\u00edguez-Pombo","year":"2024","journal-title":"Elsevier BV"},{"key":"10.1016\/j.ejpb.2026.115211_b0245","article-title":"3D-printed polypills for personalized medicine and precision oral drug delivery in pharmaceutical practice: a review","volume":"11","author":"Keerikkadu","year":"2025","journal-title":"International Journal of Pharmaceutics: X"},{"issue":"2","key":"10.1016\/j.ejpb.2026.115211_b0480","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1331\/JAPhA.2013.12217","article-title":"Three-dimensional drug printing: a structured review","volume":"53","author":"Ursan","year":"2013","journal-title":"J. Am. Pharm. Assoc."},{"issue":"12","key":"10.1016\/j.ejpb.2026.115211_b0025","doi-asserted-by":"crossref","first-page":"4501","DOI":"10.1007\/s13346-025-01966-x","article-title":"Toward a harmonized regulatory framework for 3D-printed pharmaceutical products: the role of critical feedstock materials and process parameters","volume":"15","author":"Alzhrani","year":"2025","journal-title":"Drug Deliv. Transl. Res."},{"key":"10.1016\/j.ejpb.2026.115211_b0415","doi-asserted-by":"crossref","unstructured":"Rautamo, M., Tolonen, H. M., Peltoniemi, V., & Siv\u00e9n, M. (2026). Implementing printing technology in hospital pharmacy preparation \u2013 An interview study on opportunities and challenges from medicines authorities\u2019 perspective. European Journal of Pharmaceutical Sciences, 21810.1016\/j.ejps.2026.107445.","DOI":"10.1016\/j.ejps.2026.107445"},{"key":"10.1016\/j.ejpb.2026.115211_b0400","article-title":"Three-Dimensionally Printed Paediatric Medicines: Formulation, Process, and Regulatory Considerations","author":"Petrinca","year":"2026","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ejpb.2026.115211_b0040","doi-asserted-by":"crossref","unstructured":"Annereau, M., Secretan, P. -., & Do, B. (2026). A risk-based, QTPP-driven framework for semi-solid extrusion 3d printing of personalized medicines: Integrating hospital compounding and clinical trial regulation. European Journal of Pharmaceutical Sciences, 21610.1016\/j.ejps.2025.107340.","DOI":"10.1016\/j.ejps.2025.107340"}],"container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641126002328?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641126002328?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T11:12:03Z","timestamp":1788174723000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0939641126002328"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":97,"alternative-id":["S0939641126002328"],"URL":"https:\/\/doi.org\/10.1016\/j.ejpb.2026.115211","relation":{},"ISSN":["0939-6411"],"issn-type":[{"value":"0939-6411","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A systematic review of 3D printing of pharmaceutical drug products: Barriers and enablers","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutics and Biopharmaceutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejpb.2026.115211","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"115211"}}